Evidence map›Paper›PMID 41848060›Full record

ArticleJournal of the American Heart Association2026

Development and Validation of a Machine Learning Model for Incident Heart Failure Prediction in Chronic Kidney Disease: A Multicenter Cohort Study.

Yi Lu, Junzhe Chen, Shiyu Zhou, Andrew Fanuel Lukwaro, Xiao Zhang, Wenjun Yu, Haiyong Chen, Yangxin Chen, Sheng Nie, Ying Tang

Abstract readMulticenter StudyValidation Study
In one paragraph

Article in Journal of the American Heart Association, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Yi Lu *Department of Nephrology The Third Affiliated Hospital of Southern Medical University Guangzhou China.ORCID 0000-0002-7348-8903
Junzhe Chen *Department of Nephrology The Third Affiliated Hospital of Southern Medical University Guangzhou China.
Shiyu ZhouNational Clinical Research Center for Kidney Disease, State Key Laboratory of Organ Failure Research, Guangdong Provincial Institute of Nephrology, Guangdong Provincial Key Laboratory of Renal Failure Research, Division of Nephrology, Nanfang Hospital Southern Medical University Guangzhou China.
Andrew Fanuel LukwaroDepartment of Nephrology The Third Affiliated Hospital of Southern Medical University Guangzhou China.
Xiao ZhangDepartment of Nephrology The Third Affiliated Hospital of Southern Medical University Guangzhou China.ORCID 0009-0007-8476-2537
Wenjun YuDepartment of Nephrology The Third Affiliated Hospital of Southern Medical University Guangzhou China.ORCID 0000-0003-3941-5265
Haiyong ChenSchool of Chinese Medicine, Li Ka Shing Faculty of Medicine The University of Hong Kong Hong Kong China.ORCID 0000-0002-4889-2752
Yangxin ChenDepartment of Cardiology, Sun Yat sen Memorial Hospital Sun Yat sen University Guangzhou China.ORCID 0000-0003-2051-9320
Sheng NieNational Clinical Research Center for Kidney Disease, State Key Laboratory of Organ Failure Research, Guangdong Provincial Institute of Nephrology, Guangdong Provincial Key Laboratory of Renal Failure Research, Division of Nephrology, Nanfang Hospital Southern Medical University Guangzhou China.ORCID 0000-0002-8267-7909
Ying TangDepartment of Nephrology The Third Affiliated Hospital of Southern Medical University Guangzhou China.ORCID 0009-0000-5991-4753

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundChronic kidney disease (CKD) and heart failure (HF) share pathophysiological mechanisms, rendering HF one of the most burdensome cardiovascular complication in CKD. Current HF prediction models, derived from the general population, exhibit limited accuracy in CKD, thus necessitating a CKD-specific risk model and clinical implementation.

methodsThe development set comprised 52 251 patients with CKD from the China Renal Data System (70% training; 30% internal validation). External validation used 21 798 patients from independent Chinese hospitals and 3323 UK Biobank participants. Outcome was 5-year new-onset HF. Five machine learning models were developed, with performance assessed via area under the curve and compared using DeLong test. The top-performing extreme gradient boosting model was simplified via forward stepwise selection; feature importance quantified using Shapley additive explanations.

resultsIn the Chinese external validation cohort, the extreme gradient boosting model outperformed others (area under the curve, 0.879 [95% CI, 0.871-0.887]; DeLong

conclusionsThe 9-variable extreme gradient boosting model tailored for patients with CKD may help predict HF risk in this high-risk population. Validation across diverse populations is warranted to confirm its generalizability.

Indexed as

Heart FailureMachine LearningRenal Insufficiency, ChronicAgedBoosting Machine Learning AlgorithmsChinaFemaleGlomerular Filtration RateHumansIncidenceMaleMiddle AgedPrediction AlgorithmsPredictive Learning ModelsPredictive Value of TestsPrognosischronic kidney diseaseelectronic health recordsheart failuremachine learningprediction model

Identifiers

PMID41848060
PMCPMC13279098

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.